Jill Henrich, EVP, Global Head RA & Quality at Atara Biotherapeutics, Inc. (ATRA), sold 3,267 shares at $0.39 ($1K) on 2023-11-16, disclosed to the SEC on 2023-11-20.
Open-market sale of $1k ATRA by EVP, Global Head RA & Quality. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ATRA | SELL | 2024-08-20 | $6K | — | Filing → |
| ATRA | SELL | 2024-05-20 | $16K | — | Filing → |
| ATRA | SELL | 2024-03-06 | $3K | — | Filing → |